Hainan Poly Pharm. Co., Ltd reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 373.17 million compared to CNY 367.93 million a year ago.

Revenue was CNY 373.17 million compared to CNY 367.93 million a year ago. Net income was CNY 138.43 million compared to CNY 161.78 million a year ago. Basic earnings per share from continuing operations was CNY 0.32 compared to CNY 0.37 a year ago.

Diluted earnings per share from continuing operations was CNY 0.32 compared to CNY 0.37 a year ago.